Table 4.
Effect of BP Status on GCIPL: Mediation Analysis
| Controls + Low BP | Controls + Treated AHT | Controls + Untreated AHT | ||||
|---|---|---|---|---|---|---|
| (Group 2 + Group 1) | (Group 2 + Group 3) | (Group 2 + Group 4) | ||||
| Effect | P | Effect | P | Effect | P | |
| Mediation Step 1 | ||||||
| GCIPL ∼ MAP | bMAP = 0.09 | 0.052 | bMAP = −0.10 | 0.043 | bMAP = −0.07 | 0.032 |
| Mediation Step 2 | ||||||
| RBF ∼ MAP | bMAP = 0.27 | 0.020 | ||||
| RVR ∼ MAP | bMAP = 0.005 | 0.008 | bMAP = 0.005 | 0.0003 | ||
| AR ∼ MAP | bMAP = 0.17 | 0.015 | ||||
| Mediation Step 3 | ||||||
| GCIPL ∼ MAP + RBF | bMAP = 0.05 | 0.30 | ||||
| bRBF = 0.16 | 0.003 | |||||
| GCIPL ∼ MAP + RVR | bMAP = −0.04 | 0.42 | bMAP = −0.03 | 0.51 | ||
| bRVR = −11.87 | 0.001 | bRVR = −10.23 | 0.022 | |||
| GCIPL ∼ MAP + AR | bMAP = −0.06 | 0.21 | ||||
| bAR = −0.21 | 0.042 | |||||
| GCIPL ∼ MAP + RVR + AR | bMAP = −0.04 | 0.40 | ||||
| bRVR = −27.37 | 0.001 | |||||
| bAR = 0.47 | 0.032 | |||||
| Sobel test | 0.059 | RVR: 0.041; AR: 0.095 | 0.031 | |||